✦ LIBER ✦
KRAS and BRAF Mutations in Advanced Colorectal Cancer Are Associated With Poor Prognosis but Do Not Preclude Benefit From Oxaliplatin or Irinotecan: Results From the MRC FOCUS Trial
✍ Scribed by Richman, S. D.; Seymour, M. T.; Chambers, P.; Elliott, F.; Daly, C. L.; Meade, A. M.; Taylor, G.; Barrett, J. H.; Quirke, P.
- Book ID
- 119973300
- Publisher
- American Society of Clinical Oncology
- Year
- 2009
- Tongue
- English
- Weight
- 164 KB
- Volume
- 27
- Category
- Article
- ISSN
- 0732-183X
No coin nor oath required. For personal study only.